Jacks Lee
CIK 1935943 · last filed 2026-06-16
Jacks Lee is a corporate insider who has filed 8 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for PCVX, was dated Jun 16, 2026. Current disclosed insider exposure totals $399.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$399.6K
2
8
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCVX | Director | 6,856 | $58.29 | $399.6K | $0 | 4 | 2026-06-16 |
| G1 Therapeutics, Inc. (GTHX) Delisted | Director | 0 | $7.15 | $0 | $0 | 4 | 2024-09-18 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-16 | PCVX | Grant (A) | +2,265 | $0 | EDGAR |
| 2025-06-16 | PCVX | Grant (A) | +3,041 | $0 | EDGAR |
| 2024-09-18 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | −20,000 | $0 | EDGAR |
| 2024-06-14 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2024-06-10 | PCVX | Grant (A) | +1,550 | $0 | EDGAR |
| 2023-11-29 | PCVX | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2022-06-29 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.